NVO
Novo-Nordisk A/S
stockNYSEADR
At CloseOct 23, 2026 3:59:56 PM EDT
39.03USD-1.014%(-0.40)9,120,668
Pre-marketOct 23, 2026 9:29:30 AM EDT
39.27USD-0.406%(-0.16)
After-hoursOct 23, 2026 4:57:30 PM EDT
38.90USD-0.333%(-0.13)
Loading…
Loading…
172.35B
Healthcare
Biotechnology
HQ
Bagsvaerd, Bagsvaerd, Denmark
57,089
Previous Close
$39.43
Beta
1.01
52-Week High
$64.16 2026-01-23
52-Week Low
$35.12 2026-03-30
SMA 50
$42.06
SMA 200
$44.77
Avg. Vol 10D
9.48M
Avg. Vol 30D
13.39M
Avg. Vol 90D
12.14M
Relative Vol
0.55
4.41B
3.17B
71.90%
31,622,458
1.00%
1.74
54%/46%
37.50%
21.32%
0.3700%
10,000,000
192
7,421
22,844
Nov 4, 2026 (11d)
Mar 31, 2025 · $1.099
Sep 20, 2023 · 2-for-1
Oct 23, 2026
Oct 22, 2026
What Is the Peptide Economy? Beyond the GLP-1 Boom · 
ETF Trends
Bristol Myers Squibb vs. Novo Nordisk: Stable Scale vs. GLP-1 Volatility · 
The Motley Fool
Oct 21, 2026
Where Will Novo Stock Be in 10 Years? · The Motley Fool
NVO Profile
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd, Denmark, with production facilities in nine countries and affiliates or offices in five countries.
NVO Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 38.83 | 2026-10-16 | +0.58% | -0.603 |
| 1M | 38.17 | 2026-09-23 | +2.32% | 0.243 |
| 3M | 48.18 | 2026-07-23 | -18.94% | -0.367 |
| 6M | 38.52 | 2026-04-23 | +1.39% | 0.082 |
| 1Y | 53.23 | 2025-10-23 | -26.63% | 1.006 |
| 2Y | 115.74 | 2024-10-23 | -66.26% | — |
| 5Y | 53.01 | 2021-10-22 | -26.32% | 0.671 |
NVO Stock Summary
Novo-Nordisk A/S (NYSE:NVO) stock price today is $39.06, and today's volume is 7,429,781. NVO is down 0.951% today. The 30 day average volume is 13.39M. NVO market cap is $172.35B with 4.41B shares outstanding.